Inhibition of Mycobacterial Growth In Vitro following Primary but Not Secondary Vaccination with Mycobacterium bovis BCG

Despite the widespread use of the Mycobacterium bovis BCG vaccine, there are more than 9 million new cases of tuberculosis (TB) every year, and there is an urgent need for better TB vaccines. TB vaccine candidates are selected for evaluation based in part on the detection of an antigen-specific gamm...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fletcher, Helen A., Tanner, Rachel, Wallis, Robert S., Meyer, Joel, Manjaly, Zita-Rose, Harris, Stephanie, Satti, Iman, Silver, Richard F., Hoft, Dan, Kampmann, Beate, Walker, K. Barry, Dockrell, Hazel M., Fruth, Uli, Barker, Lew, Brennan, Michael J., McShane, Helen
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2013
Sujets:
Vaccines
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837779/
https://ncbi.nlm.nih.gov/pubmed/23986316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00427-13
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires